Eosinophilic esophagitis in cystic fibrosis: a case series and review of the literature. 2013

Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
Division of Pediatric Pulmonology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, United States. jennifer_goralski@med.unc.edu

Patients with cystic fibrosis (CF) frequently experience gastrointestinal symptoms including nausea, emesis, malnutrition and indigestion; diseases such as gastroesophageal reflux disease (GERD), distal intestinal obstructive syndrome, and cholelithiasis are commonly implicated. We have recently diagnosed eosinophilic esophagitis (EoE) in three patients with CF. EoE is a TH-2 driven, allergen-mediated disease which causes esophageal eosinophilia and presents with symptoms of nausea, feeding intolerance, regurgitation, and dysphagia. EoE is diagnosed when esophageal biopsies reveal greater than 15 eosinophils per high power field in the setting of the appropriate clinical scenario and after exclusion of other causes of esophageal eosinophilia. Although described with increasing frequently in the gastrointestinal literature, there have been no prior cases documenting the co-existence of EoE and CF. We speculate that this is related to lack of familiarity with EoE symptoms by CF providers. We present three patients with CF diagnosed with EoE and review the current literature regarding diagnosis and management, focusing on management issues in patients with CF.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D057765 Eosinophilic Esophagitis Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens. Chronic Esophagitis, Eosinophilic,Esophagitis, Eosinophilic,Chronic Esophagitides, Eosinophilic,Eosinophilic Chronic Esophagitides,Eosinophilic Chronic Esophagitis,Eosinophilic Esophagitides,Esophagitides, Eosinophilic,Esophagitides, Eosinophilic Chronic,Esophagitis, Eosinophilic Chronic
D019819 Budesonide A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS. Tarpeyo,Budesonide, (R)-Isomer,Budesonide, (S)-Isomer,Horacort,Pulmicort,Rhinocort

Related Publications

Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
June 2022, Pediatric pulmonology,
Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
October 2007, Digestive diseases and sciences,
Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
December 2010, Clinical journal of gastroenterology,
Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
January 2022, Therapeutic advances in gastroenterology,
Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
June 2017, Endoscopy international open,
Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
December 2011, Digestive diseases and sciences,
Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
January 2018, Pathology, research and practice,
Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
April 2015, Asia Pacific allergy,
Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
October 2016, Medicine,
Jennifer L Goralski, and Daniel M Lercher, and Stephanie D Davis, and Evan S Dellon
January 2021, Case reports in gastrointestinal medicine,
Copied contents to your clipboard!